Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

Pancreatic Cancer Thromboembolism Review Maps Risk and Anticoagulation

Review details why pancreatic cancer drives thromboembolism, why risk models miss cases, and how LMWH, DOACs, and factor XI inhibitors fit care.

A review details how cancer cells use antioxidant defenses, NRF2 signaling, and redox rewiring to survive therapy and…

Ecuador became the first Americas country to use the WHO-led childhood cancer medicines platform, strengthening access, logistics, and…

Aneurin Bevan University Health Board is recruiting an Outpatients Manager for its Unified Breast Unit, a role centered…

A genome-wide CRISPR screen identified Wnt signaling as a regulator of lipid accumulation in APOE4 oligodendrocytes, pointing to…

A pan-cancer nucleosome atlas across 410 tumors links chromatin organization to heterogeneity and supports cfDNA-based cancer detection.

A Nature Reviews Clinical Oncology review explains why glioblastoma targeted therapy remains limited and what may improve CNS…

A Nature Reviews Clinical Oncology review maps where AI can streamline oncology trials now and where synthetic controls…

Phase III LITESPARK-011 showed belzutifan plus lenvatinib improved outcomes versus cabozantinib in previously treated advanced clear-cell renal cell…

A Nature Reviews commentary says cancer proteomics needs functional, annotated maps to become clinically useful in precision oncology.

Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

In Brief The 5-minute rounds